November 13, 2015 6:25pm

 

Oversold pumped to a positive equivalence and then chain sawed!

I say today what others won't, so you can do what others can't - access insight into sector sentiment and share pricing. 

 

 

I also mine and organize opinions from heterogeneous information sources that could be very useful for investors!  Opinion extraction, summarization and tracking are three important techniques for monitoring and understanding sentiment.

 

 

U.S. stocks traded more than 1% lower Friday, pressured by a continued decline in oil prices and soft reports on the health of the consumer.

The NASDAQ closed DOWN -77.20 or -1.54% to 4,927.88 and the DOW or -182.26 or -1.04% to 17,265.81.

 

 

Henry’omics:

The stem, cell and gene therapy RegMed sector opened negative and flipped positive (of 43 covered companies) to close in negative territory!

  • The NASDAQ composite fell more than 1% with the iShares Nasdaq Biotechnology ETF (IBB) was one of the few advancers in Friday's session, trading more than 1% higher as the close approached.

The NASDAQ fell below the psychologically key level of 5,000 for the first time in intraday trade since Oct. 23. The index has not closed below that level since Oct. 22 and is the only major average still positive year-to-date.

  • The major indexes pared losses slightly in midday trade before holding lower.

My fear gauge – The CBOE Volatility Index (VIX) closed Friday above 20 after Thursday’s near 17 following Wednesday’s near 16 having barely moved on Tuesday to near 15 from Monday’s below 15 following Friday’s above 16.

 

 

A day in the life of the stem, cell and gene therapy RegMed (SCGT & RM) sector:

  • The SCGT & RM equities opened negative with an Advance/Decline line (A/DL) of 10/30 and 3 flats;
  • The mid-day popped with a positive A/DL of 13/27 and 3 flats;
  • The closing bell rang negative to end Friday’s session with an A/DL of 15/26 and 2 flats.

 

 

Friday’s trading indications:  3 hits/ 2 miss

  • Capricor (CAPR) closed FLAT - hit;
  • BioLife Solutions (BLFS) closed DOWN -$0.10 – hit;
  • Harvard Apparatus RM (HART) closed DOWN -$0.11– hit;
  • Kite Pharma (KITE) closed UP +$1.52 – miss;
  • Verastem (VSTM) closed DOWN -$0.01 – miss;

 

 

Earnings:

Most would agree the fundamental situation has not changed much, with exception of a handful of “so-so” received financial results/earnings reports, which is different than the previous quarter:

  • Vericel (VCEL) reported <11/13> a Q3/15 net loss of -$4.4 M or -$0.26 per share with $18.7 M in cash. VCEL closed DOWN -$0.03 to $1.93;
  • Histogenics (VCEL) reported <11/13> a Q3/15 net loss of -$8.1 M or -$0.61 per share with $37.7 M in cash. HSGX closed DOWN -$0.51 to $3.68;

 

 

Riding the indexes and ETFs roller-coaster:

  • The iShares Biotechnology Stocks ETF (IBB) closed Friday UP +3.53 or +1.10% after Thursday’s decline of -6.74 or -2.06% following Wednesday’s decline of -5.11 or -1.54% after Tuesday’s +1.38 or +0.42% following Monday’s advance of +0.34 or +0.10%;
  • The NASDAQ Biotechnology index (NBI) closed Friday UP +36.28 or +1.08% after Thursday’s decline of -72.39 or -2.12% following Wednesday’s decline of -49.32 or -1.42% after Tuesday‘s advance of 13.99 or +0.40% following Monday’s advance of +2.30 or +0.07%;
  • The Russell 2000 (IWM) closed Friday DOWN -0.83 or -0.72% after Thursday’s decline of - 2.24 or -1.91% following Wednesday’s -1.03 or -0.87% after Tuesday’s +0.35 or +0.30% following Monday’s decline of -1.40 or -1.17%;
  • The SPDR SD&P Biotech ETF (XBI) closed Friday -0.05 or -0.07% after Thursday’s decline of  -1.42 or -2.03% following Wednesday’s decline of -1.20 or -1.69% on Wednesday after Tuesday’s decline of  -0.25 or -0.35% following Monday’s advance of +0.63 or +0.89%;

 

 

Dosing the sector – what a day for the 43 Patients:

  • Open: NEGATIVE with 30 decliners, 10 advances and 3 flats;
  • Mid-day (1 pm): POSITIVE with 13 decliners, 27 advancers and 3 flats;
  • Closing bell: NEGATIVE with 26 decliner, 15 advancers and 2 flats

 

 

Who was UP – top 5:

  • Kite Pharma (KITE) closed up +$1.52 to $81.33;
  • Aduro Biotech (ARDO) +$0.63 to $29.09;
  • Applied Genetic Technologies (AGTC) +$0.57 to $15.92;
  • Avalanche Biotech (AAVL) +$0.31 to $8.09;
  • Fibrocell (FCSC) closed up +$0.22 to $5.26

 

 

Who closed down – top 5:

  • Intrexon (XON) closed down -$3.38 to $35.34;
  • Bluebird bio (BLUE) -$0.90 to $71.39;
  • Cellectis ADR (CLLS) -$0.53 to $38.53;
  • Histogenics (HSGX) -$0.51 to $3.68;
  • Osiris (OSIR) closed down -$0.34 to $14.31;

 

 

Flat:

  • Mesoblast ADR (USOTC: MBLTY) at $12.33;
  • Pluristem (PSTI) at $1.53

 

 

All investments are subject to risks. Investors should consider investment objectives. The information included above as well as individual companies and/or securities mentioned should only construed as an indication from any RMi reviews.

The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.